Metabolomics Services Market, By Type of Technique (Detection Techniques, Separation Techniques), By Type of Service (Targeted Metabolomics, Untargeted Metabolomics, Metabolite Profiling, Biomarker Discovery, and Other Services), By Application (Drug Discovery, Toxicology Testing, Biomarker Discovery, Nutritional Research, Disease Diagnosis, and Other Applications), By End User (Academic and Research Institutes and Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Diagnostic Laboratories, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : Dec 2024

Code : CMI180

Pages :256

Formats :

Excel and PDF

Industry : Clinical Diagnostic

Regional Analysis

Metabolomics Services Market Regional Insights

To learn more about this report, Request sample copy

North America Metabolomics Services Market Trends

North America's dominance in the metabolomics services market, accounting for a 39.3% share, can be attributed to the strong presence of leading service providers and research institutes actively engaged in metabolomics research in 2024. Growing applications across various end-use industries such as pharmaceutical and biotechnology have further boosted market growth.

Asia Pacific Metabolomics Services Market Trends

The Asia Pacific region exhibits the fastest growth with share of 25.7% in 2024, driven by increasing R&D investments by governments as well as private players. Expanding healthcare and biopharmaceutical industries have augmented demand for specialized metabolomics services to support various analytical requirements. Rising awareness regarding applications in precision medicine is another key factor accentuating market opportunities.

Metabolomics Services Market Outlook for Key countries

U.S. Metabolomics Services Market Trends

The U.S. metabolomics services market is well-established with extensive metabolomics research activities. As chronic diseases rise, the use of metabolomics in research and therapy development is set to grow, driving market expansion. For instance, the Centers for Disease Control and Prevention reports that six in 10 U.S. adults have a chronic disease, and four in 10 have two or more, contributing to over US$ 4.1 trillion in annual healthcare costs. Metabolomics, crucial in identifying biomarkers and understanding disease mechanisms, supports advanced treatments and drug discovery.

China Metabolomics Services Market Trends

China metabolomics services market is growing at a quick pace supported by strong government funding for metabolomics as part of precision medicine initiatives. Shimadzu (China) Co., Ltd., in collaboration with the Dalian Institute of Chemical Physics, Chinese Academy of Sciences, established the Laboratory for Innovative Omics Research to address societal challenges through metabolomics research. This partnership aims to accelerate advancements in the diagnosis of diseases, drug discovery, and other specialized fields like food products.

U.K. Metabolomics Services Market Trends

The U.K. metabolomics services market is growing due to strong collaborations between industry leaders and renowned research institutions. LECO Instruments UK Ltd., a subsidiary of LECO Corporation, announced a training and research collaboration with the Liverpool Training Centre for Metabolomics and the Centre for Metabolomics Research at the University of Liverpool. Renowned globally for their expertise in analytical chemistry and metabolomics applications, these centers will partner with LECO to advance training and research in metabolomics.

India Metabolomics Services Market Trends

The India metabolomics services market is gaining traction due to increasing healthcare investments. In December 2023, the Indian government allocated US$ 20 million for research in metabolomics to enhance disease diagnosis and treatment options.